Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Oral W/O microemulsion preparation of cyclo-trans-4-hydroxyprolyl-L-serine and preparation method of same

A technology of hydoxyserin and milk preparations, which is applied in the field of oral hydoxyserin W/O microemulsion preparations and its preparation, which can solve the problems of difficult to pass through the biofilm barrier, incomplete oral absorption, poor membrane permeability, etc., and achieve stable quality Controllable, bioavailability-enhancing, toxicity-reducing effects

Inactive Publication Date: 2012-07-11
DALIAN MEDICAL UNIVERSITY
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, Hydroxyserin has good water solubility and small molecular weight (about 200 Daltons), which is a drug with low permeability, and the permeability coefficient is about 5.01×10 -6 (cm / sec), that is, the membrane permeability of oral drugs is poor, and it is difficult to pass through the biofilm barrier
In addition, due to the presence of a large number of peptidases and proteolytic enzymes in the gastrointestinal tract, direct oral administration of hydroxyl silk peptide is prone to first-pass effect and is eliminated by liver metabolism.
The result of the experiment was that after the rats were directly orally administered with hydroxylase peptide, t 1 / 2 Only 30~40min, the oral absorption is incomplete, and the bioavailability is about 30%. The therapeutic effect can only be achieved through frequent administration, which is time-consuming and laborious.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Oral W/O microemulsion preparation of cyclo-trans-4-hydroxyprolyl-L-serine and preparation method of same
  • Oral W/O microemulsion preparation of cyclo-trans-4-hydroxyprolyl-L-serine and preparation method of same
  • Oral W/O microemulsion preparation of cyclo-trans-4-hydroxyprolyl-L-serine and preparation method of same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 2

[0021] a. Take 3.706 g of emulsified oil triolein, 1.5625 g of emulsifier Span 80 and 0.3125 g of Tween 80, and 3.751 g of absolute ethanol, and magnetically stir at room temperature to obtain an oil phase;

[0022] b. Weigh 35mg of Hydroxyserin and dissolve it in 1ml of deionized water by ultrasonic to obtain the water phase;

[0023] c. Drop the water phase into the oil phase at room temperature, stir and mix evenly to obtain a clear oily solution, and use a compression method to obtain soft capsules to obtain the oral microemulsion preparation of hydroxyl silk peptide.

[0024] The average particle size of the obtained microemulsion is 80nm, and the content of hydroxyl serin is 0.33% (W / W).

Embodiment 3

[0026] a. Take 1.849g of emulsified oil triolein, 3.565g of emulsifier monocaprylic / capric glyceride (ODO-L), and 3.565g of absolute ethanol, and stir them evenly with magnetic force at room temperature to obtain the oil phase;

[0027] b. Weigh 40mg of Hydroxyserin, dissolve it in 1.2mL of deionized water by ultrasonic to obtain the aqueous phase;

[0028] c. Drop the water phase into the oil phase at room temperature, stir and mix evenly to obtain a clear oily solution, and use a compression method to obtain soft capsules to obtain the oral microemulsion preparation of hydroxyl silk peptide.

[0029] The average particle size of the obtained microemulsion is 70nm, and the content of hydroxyl serin is 0.39% (W / W).

[0030] Observing the oral microemulsion preparation (oily solution with clear appearance) of the embodiment 3 of the present invention with a transmission electron microscope, its transmission electron microscope picture is as follows: figure 1 As shown, the oral...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
The average particle sizeaaaaaaaaaa
The average particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention discloses an oral W / O microemulsion preparation of cyclo-trans-4-hydroxyprolyl-L-serine, which is advantageous in that the half-life period of cyclo-trans-4-hydroxyprolyl-L-serine is prolonged and the oral bioavailability of cyclo-trans-4-hydroxyprolyl-L-serine is improved. The oral W / O microemulsion preparation contains the following components in percentage by weight: 0.3% to 0.4% of cyclo-trans-4-hydroxyprolyl-L-serine, 10% to 40% of medicinal oil, 10% to 50% of emulsifiers, 10% to 50% of anhydrous ethanol and deionized water. The preparation method comprises the following steps: thoroughly mixing emulsifiers, anhydrous ethanol and medicinal oil at the given ratio to obtain an oil phase; adding the given amount of cyclo-trans-4-hydroxyprolyl-L-serine into deionized water and dissolving thoroughly to obtain a water phase; and slowly adding the water phase into the oil phase while magnetically stirring, and stopping stirring until a clear oily liquid is obtained.

Description

technical field [0001] The invention relates to a hyseride preparation, in particular to an oral hyseride W / O microemulsion preparation capable of prolonging the half-life of the hyseride and improving the oral bioavailability of the hyseride and a preparation method thereof. Background technique: [0002] Hydroxyserin, whose chemical name is cyclotrans-4 L-hydroxyprolylserine, is an active dipeptide extracted and isolated from the Japanese anti-hepatitis drug Laennec (trade name of human placental hydrolyzate). Its chemical structure is as follows : [0003] [0004] At present, Hydroxyserin is artificially synthesized by Japan Biopharmaceuticals Co., Ltd. and has been sold publicly. Existing experiments have shown that hydroxyl serin has good anti-hepatitis activity and little adverse reaction. However, Hydroxyserin has good water solubility and small molecular weight (about 200 Daltons), which is a drug with low permeability, and the permeability coefficient is about...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/107A61K38/05A61P1/16
Inventor 刘克辛李磊王长远蔡芸田燕
Owner DALIAN MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products